FY2026 EPS Estimates for Revvity Increased by Zacks Research

Revvity Inc. (NYSE:RVTYFree Report) – Equities researchers at Zacks Research boosted their FY2026 EPS estimates for shares of Revvity in a research report issued to clients and investors on Friday, September 4th. Zacks Research analyst Team now anticipates that the company will earn $5.40 per share for the year, up from their prior estimate of $5.38. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Revvity’s current full-year earnings is $5.37 per share. Zacks Research also issued estimates for Revvity’s Q1 2027 earnings at $1.19 EPS, Q2 2027 earnings at $1.53 EPS, FY2027 earnings at $5.93 EPS, Q1 2028 earnings at $1.35 EPS and FY2028 earnings at $6.62 EPS.

Revvity (NYSE:RVTYGet Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same quarter last year, the firm earned $1.18 earnings per share. The firm’s revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS.

RVTY has been the subject of several other research reports. KeyCorp increased their price objective on Revvity from $125.00 to $165.00 and gave the stock an “overweight” rating in a research report on Friday. Evercore reaffirmed an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Wolfe Research initiated coverage on shares of Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Finally, Sanford C. Bernstein began coverage on Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price target on the stock. Four analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Revvity presently has a consensus rating of “Hold” and a consensus target price of $114.77.

View Our Latest Report on Revvity

Revvity Stock Up 0.0%

RVTY opened at $130.24 on Monday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The business has a 50 day simple moving average of $116.79 and a 200-day simple moving average of $102.54. The stock has a market capitalization of $14.53 billion, a P/E ratio of 62.02, a P/E/G ratio of 2.37 and a beta of 1.09. Revvity has a 12 month low of $81.22 and a 12 month high of $133.00.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio is 13.33%.

Hedge Funds Weigh In On Revvity

A number of institutional investors have recently made changes to their positions in RVTY. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Revvity in the second quarter valued at $823,000. California State Teachers Retirement System raised its stake in Revvity by 10,607.8% in the 2nd quarter. California State Teachers Retirement System now owns 14,328,063 shares of the company’s stock valued at $1,594,140,000 after purchasing an additional 14,194,254 shares during the last quarter. Angeles Wealth Management LLC lifted its holdings in Revvity by 2.0% in the 2nd quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company’s stock valued at $646,000 after purchasing an additional 112 shares in the last quarter. Syon Capital LLC lifted its holdings in Revvity by 9.1% in the 2nd quarter. Syon Capital LLC now owns 4,442 shares of the company’s stock valued at $494,000 after purchasing an additional 369 shares in the last quarter. Finally, NEOS Investment Management LLC boosted its stake in shares of Revvity by 13.2% during the 2nd quarter. NEOS Investment Management LLC now owns 17,388 shares of the company’s stock worth $1,935,000 after purchasing an additional 2,031 shares during the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Company Profile

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Recommended Stories

Earnings History and Estimates for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.